HSP90AB1 and colorectal carcinoma: Thus, decreased HSP90AB1 expression in CRC with a poorer prognosis may represent an inadvertent bystander effect resulting from a CRC-specific selective pressure toward mTOR pathway activation as a consequence of USP22 downregulation6.